gip vs glp 1 receptors Science Behind and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 & GIP Agonists |

Discover medical weight loss with proven medications, tailored plans, and expert guidance for lasting results

Exceedingly short half-life (12 min) of GLP-1 limits its therapeutic applicability, and the implication of its new variants is under question

New genetic research finds that people with the PAM gene variant p.S539W have a harder time processing the GLP-1 hormone and may require alternative medications for weight loss and blood sugar management.

This review covers everything you need to know.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...